texto impreso

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.

Windecker, Stephan ; Lopes, Renato D. ; Massaro, Tyler ; Jones-Burton, Charlotte ; Granger, Christopher B. ; Aronson, Ronald ; Heizer, Gretchen ; Goodman, Shaun G. ; Darius, Harald ; Jones, W. Schuyler ; Aschermann, Michael ; Brieger, David ; Cura, Fernando ; Engstrom, Thomas ; Fridrich, Viliam ; Halvorsen, Sigrun ; Huber, Kurt ; Kang, Hyun-Jae ; Leiva-Pons, Jose L. ; Lewis, Basil S. ; Malaga, German ; Meneveau, Nicolas ; Merkely, Bela ; Milicic, Davor ; Morais, Joao ; Potpara, Tatjana S. ; Raev, Dimitar ; Sabate, Manel ; de Waha-Thiele, Suzanne ; Welsh, Robert C. ; Xavier, Denis ; Mehran, Roxana ; Alexander, John H. | American Heart Association | 2019-12-06T21:04:48Z

Background: The safety and efficacy of antithrombotic regimens may differ between patients with atrial fibrillation (AF) who have acute coronary syndromes (ACS), treated medically or with percutaneous coronary intervention (PCI), and those under[...]

Más información...

Añadir a la cesta

Ningún comentario para este registro.

En línea: